DILH
CELG

Dai-ichi Life Holdings’s Celgene Corp CELG Stock Holding History

Dai-ichi Life Holdings’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-109,075
Closed -$11.4M – 555
2016
Q3 		$11.4M Sell
109,075
-97
-0.1% -$10.5K 0.35% 57
2016
Q2 		$10.8M Sell
109,172
-29,354
-21% -$3.04M 0.32% 71
2016
Q1 		$13.9M Buy
138,526
+4,846
+4% +$499K 0.42% 50
2015
Q4 		$16M Sell
133,680
-3,706
-3% -$429K 0.5% 37
2015
Q3 		$14.9M Buy
137,386
+1,551
+1% +$192K 0.46% 40
2015
Q2 		$15.7M Sell
135,835
-18,369
-12% -$2.1M 0.47% 35
2015
Q1 		$17.8M Buy
154,204
+13,852
+10% +$1.66M 0.5% 42
2014
Q4 		$15.7M Sell
140,352
-5,237
-4% -$552K 0.45% 41
2014
Q3 		$13.8M Sell
145,589
-495
-0.3% -$44.7K 0.41% 46
2014
Q2 		$12.5M Sell
146,084
-28,240
-16% -$2.15M 0.39% 57
2014
Q1 		$12.2M Sell
174,324
-24,698
-12% -$1.96M 0.39% 57
2013
Q4 		$16.8M Buy
199,022
+19,360
+11% +$1.53M 0.52% 37
2013
Q3 		$13.8M Sell
179,662
-37,722
-17% -$2.64M 0.48% 45
2013
Q2 		$12.7M Buy
+217,384
New +$13.1M 0.45% 49

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dai-ichi Life Holdings's CELG Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 109,075 shares — an estimated $11.4M sold.

Dai-ichi Life Holdings first reported a position in CELG in Q2 2013 and held it in 14 quarters. The position peaked at $17.8M in Q1 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 109,075 Celgene Corp shares in Q4 2016, an estimated $11.4M.
  • Dai-ichi Life Holdings first reported a position in Celgene Corp in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Celgene Corp position peaked at $17.8M in Q1 2015.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.